At Herbsea, we “celebrate” all months devoted to awareness of preventable diseases, and urge our loyal family of customers to support the foundations that raise money for cures and care. October is the month when the medical community has urged caregivers, organizations, businesses and “just plain folks” to be proactive for the women in their lives to be conscious of preventing their risk of breast cancer.
The following updated breast cancer statistics are from http://www.breastcancer.org.
- About 1 in 8 U.S. women (about 12%) will develop invasive breast cancer.
- In 2017, an estimated 252,710 new cases of invasive breast cancer are expected to be diagnosed in women in the U.S., along with 63,410 new cases of non-invasive (in situ) breast cancer.
- About 2,470 new cases of invasive breast cancer are expected to be diagnosed in men in 2017. A man’s lifetime risk of breast cancer is about 1 in 1,000.
- Besides skin cancer, breast cancer is the most commonly diagnosed cancer among American women. In 2017, it’s estimated that about 30% of newly diagnosed cancers in women will be breast cancers.
- As of March 2017, there are more than 3.1 million women with a history of breast cancer in the U.S. This includes women currently being treated and women who have finished treatment
Breast cancer is characterized by abnormally growing cells in breast tissue that divide much more rapidly than normal cells. This causes an accumulation that becomes a lump. Frequently, doctors have found that breast cancer tends to start in the milk-producing ducts but can begin anywhere in the breast.
Mammograms performed annually will go a long way to helping to save lives should cancerous growths be occurring in their breasts. According to the American Cancer Society (ACS), the increase in screenings and awareness has also increased early detection.
It is now possible to find out if you carry the BRCA1 and/or BRCA2 gene mutation that increases the lifetime risk of developing breast cancer as much as 80 percent. If you have had female relatives with breast cancer, it is recommended to get this test.